#FDAApproval #Jascayd #Nerandomilast #IdiopathicPulmonaryFibrosis #IPF #PulmonaryFibrosis #BoehringerIngelheim #NewDrugApproval #LungHealth #FibrosisResearch #ClinicalTrials #RespiratoryMedicine #Pharmacally #DrugDevelopment #PharmaNews To view or add a comment, sign in In a major development for diabetes management and weight loss, Indias drug regulator Central Drugs Standard Control Organisation (CDSCO) has approved Ozempic (semaglutide) for use in adults with type 2 diabetes
Its success forced Novo to accelerate its R&D: Novo expanded doses, tried new combo drugs (like semaglutide+tirzepatide in development), and looked for inorganic boosts
EMF sensitivity support supplements: what I use and why The protocol follows directly from the mechanisms
Just a week in, I started feeling a difference
Anxiety is not commonly reported in available research, although individual experiences may vary
People would just say their craving, specifically, for highly processed, oily, super salty, super sweet foods just dropped off, says Richards
